↓ Skip to main content

Dove Medical Press

Article Metrics

Management of epilepsy in patients with Rett syndrome: perspectives and considerations

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
56 Mendeley
Title
Management of epilepsy in patients with Rett syndrome: perspectives and considerations
Published in
Therapeutics and Clinical Risk Management, June 2015
DOI 10.2147/tcrm.s55896
Pubmed ID
Authors

Natalija Krajnc

Abstract

Rett syndrome (RTT) is a common neurodevelopmental disorder that appears in infancy with regression of acquired motor skills, loss of purposeful activity, hand stereotypies, loss of acquired spoken language, and seizures. Epilepsy affects the majority of patients in a specific clinical stage of the disease and is drug resistant in approximately one-third of cases. The association of epilepsy and even drug-resistant epilepsy has been reported in certain genotypes of the methyl-CpG-binding protein 2 mutation, which is present in a majority of patients with classical RTT. The evolution of electroencephalographic abnormalities accompanying the clinical development of the syndrome is well described, but much less is known about the seizure semiology and the effectiveness of specific antiepileptic drugs. The aim of this review is to present the clinical and electrophysiological aspects of epilepsy in RTT and the current treatment approach.

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 21%
Student > Bachelor 10 18%
Researcher 7 13%
Other 5 9%
Student > Doctoral Student 4 7%
Other 10 18%
Unknown 8 14%
Readers by discipline Count As %
Medicine and Dentistry 14 25%
Agricultural and Biological Sciences 8 14%
Neuroscience 7 13%
Biochemistry, Genetics and Molecular Biology 5 9%
Nursing and Health Professions 4 7%
Other 6 11%
Unknown 12 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2015.
All research outputs
#7,834,175
of 12,485,238 outputs
Outputs from Therapeutics and Clinical Risk Management
#641
of 922 outputs
Outputs of similar age
#124,743
of 234,669 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#32
of 46 outputs
Altmetric has tracked 12,485,238 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 922 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 234,669 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.